Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$24.42
-1.3%
$24.24
$13.40
$26.65
$4.12B0.752.16 million shs3.34 million shs
Docusign Inc. stock logo
DOCU
Docusign
$84.59
-0.5%
$76.17
$57.58
$107.86
$17.01B1.022.70 million shs4.52 million shs
Lennar Corporation stock logo
LEN
Lennar
$127.17
-4.3%
$125.71
$98.42
$189.65
$32.94B1.333.28 million shs17.04 million shs
The ODP Corporation stock logo
ODP
ODP
$20.82
-4.6%
$19.68
$11.85
$32.21
$626.27M1.4589,213 shs963,109 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
+2.27%+2.27%-0.88%+8.98%+51.56%
Docusign Inc. stock logo
DOCU
Docusign
+0.58%+5.94%+19.94%+13.15%+50.09%
Lennar Corporation stock logo
LEN
Lennar
+0.05%-5.14%-0.93%+25.03%-29.43%
The ODP Corporation stock logo
ODP
ODP
+0.65%+2.44%+3.90%+30.74%-26.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$24.42
-1.3%
$24.24
$13.40
$26.65
$4.12B0.752.16 million shs3.34 million shs
Docusign Inc. stock logo
DOCU
Docusign
$84.59
-0.5%
$76.17
$57.58
$107.86
$17.01B1.022.70 million shs4.52 million shs
Lennar Corporation stock logo
LEN
Lennar
$127.17
-4.3%
$125.71
$98.42
$189.65
$32.94B1.333.28 million shs17.04 million shs
The ODP Corporation stock logo
ODP
ODP
$20.82
-4.6%
$19.68
$11.85
$32.21
$626.27M1.4589,213 shs963,109 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
+2.27%+2.27%-0.88%+8.98%+51.56%
Docusign Inc. stock logo
DOCU
Docusign
+0.58%+5.94%+19.94%+13.15%+50.09%
Lennar Corporation stock logo
LEN
Lennar
+0.05%-5.14%-0.93%+25.03%-29.43%
The ODP Corporation stock logo
ODP
ODP
+0.65%+2.44%+3.90%+30.74%-26.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
2.65
Moderate Buy$29.6521.40% Upside
Docusign Inc. stock logo
DOCU
Docusign
2.32
Hold$94.1411.29% Upside
Lennar Corporation stock logo
LEN
Lennar
2.22
Hold$133.084.64% Upside
The ODP Corporation stock logo
ODP
ODP
2.00
Hold$19.00-8.74% Downside

Current Analyst Ratings Breakdown

Latest LEN, ACAD, DOCU, and ODP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/18/2025
Lennar Corporation stock logo
LEN
Lennar
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$115.00 ➝ $135.00
9/11/2025
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
9/11/2025
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$35.00 ➝ $39.00
9/9/2025
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$36.00 ➝ $39.00
9/9/2025
Docusign Inc. stock logo
DOCU
Docusign
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldStrong-Buy
9/8/2025
Docusign Inc. stock logo
DOCU
Docusign
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold
9/8/2025
Docusign Inc. stock logo
DOCU
Docusign
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$86.00 ➝ $90.00
9/8/2025
Lennar Corporation stock logo
LEN
Lennar
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
9/5/2025
Docusign Inc. stock logo
DOCU
Docusign
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$95.00
9/5/2025
Docusign Inc. stock logo
DOCU
Docusign
JMP Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform$124.00
9/5/2025
Docusign Inc. stock logo
DOCU
Docusign
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$80.00 ➝ $85.00
(Data available from 9/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$957.80M4.30$0.71 per share34.33$4.40 per share5.55
Docusign Inc. stock logo
DOCU
Docusign
$3.10B5.50$2.93 per share28.89$9.89 per share8.55
Lennar Corporation stock logo
LEN
Lennar
$35.37B0.93$13.99 per share9.09$104.47 per share1.22
The ODP Corporation stock logo
ODP
ODP
$6.99B0.09$6.78 per share3.07$26.79 per share0.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$226.45M$1.3318.3632.136.1321.80%14.69%9.41%11/5/2025 (Estimated)
Docusign Inc. stock logo
DOCU
Docusign
$1.07B$1.3363.6064.084.439.08%14.01%7.14%12/4/2025 (Estimated)
Lennar Corporation stock logo
LEN
Lennar
$3.93B$12.0910.528.185.649.20%12.73%8.57%N/A
The ODP Corporation stock logo
ODP
ODP
-$3M$0.6631.554.780.540.39%11.22%2.58%11/5/2025 (Estimated)

Latest LEN, ACAD, DOCU, and ODP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/18/2025Q3 2025
Lennar Corporation stock logo
LEN
Lennar
$2.14$2.29+$0.15$2.29$9.01 billion$8.81 billion
9/4/2025Q2 2026
Docusign Inc. stock logo
DOCU
Docusign
$0.84$0.92+$0.08$0.30$780.35 million$800.64 million
8/6/2025Q2 2025
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$0.14$0.16+$0.02$0.16$263.07 million$264.57 million
8/6/2025Q2 2025
The ODP Corporation stock logo
ODP
ODP
$0.33$0.51+$0.18N/A$1.59 billion$1.59 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
N/AN/AN/AN/AN/A
Docusign Inc. stock logo
DOCU
Docusign
N/AN/AN/AN/AN/A
Lennar Corporation stock logo
LEN
Lennar
$2.001.57%N/A16.54%1 Years
The ODP Corporation stock logo
ODP
ODP
N/AN/AN/AN/AN/A

Latest LEN, ACAD, DOCU, and ODP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/19/2025
Lennar Corporation stock logo
LEN
Lennar
quarterly$0.501.9%7/3/20257/3/20257/18/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
N/A
2.91
2.83
Docusign Inc. stock logo
DOCU
Docusign
N/A
0.74
0.74
Lennar Corporation stock logo
LEN
Lennar
0.12
3.65
0.49
The ODP Corporation stock logo
ODP
ODP
0.30
0.94
0.45

Institutional Ownership

CompanyInstitutional Ownership
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
96.71%
Docusign Inc. stock logo
DOCU
Docusign
77.64%
Lennar Corporation stock logo
LEN
Lennar
81.10%
The ODP Corporation stock logo
ODP
ODP
99.56%

Insider Ownership

CompanyInsider Ownership
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
26.50%
Docusign Inc. stock logo
DOCU
Docusign
1.01%
Lennar Corporation stock logo
LEN
Lennar
10.00%
The ODP Corporation stock logo
ODP
ODP
3.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
510168.71 million124.00 millionOptionable
Docusign Inc. stock logo
DOCU
Docusign
6,838201.10 million199.07 millionOptionable
Lennar Corporation stock logo
LEN
Lennar
13,265259.01 million233.11 millionOptionable
The ODP Corporation stock logo
ODP
ODP
19,00030.08 million29.00 millionOptionable

Recent News About These Companies

Office Depot Issues Apology for Incident at Michigan Store
ODP (NASDAQ:ODP) Stock Price Down 5.6% - Time to Sell?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
ACADIA Pharmaceuticals stock logo

ACADIA Pharmaceuticals NASDAQ:ACAD

$24.42 -0.33 (-1.33%)
Closing price 04:00 PM Eastern
Extended Trading
$24.42 0.00 (0.00%)
As of 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-101 whixh is in Phase III for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 which is in Phase II for the treatment of Alzheimer's disease psychosis; ACP-2591 that is in Phase I for Rett syndrome and Fragile X syndrome; preclinical antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms. It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.

Docusign stock logo

Docusign NASDAQ:DOCU

$84.59 -0.42 (-0.49%)
Closing price 04:00 PM Eastern
Extended Trading
$84.50 -0.09 (-0.11%)
As of 06:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DocuSign, Inc. provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce. It also provides Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; Monitor that uses advanced analytics to track DocuSign eSignature web, mobile, and API account; Notary which enables notaries public to conduct remote online notarization transactions; and Web Forms, a web forms that quickly draft agreements using pre-populated data from completed forms or external systems via APIs. In addition, the company offers Rooms for Real Estate that provides a way for brokers and agents to manage the entire real estate transaction digitally. Signature and CLM are FedRAMP, an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct and partner-assisted sales, and digital self-service purchasing. DocuSign, Inc. was incorporated in 2003 and is headquartered in San Francisco, California.

Lennar stock logo

Lennar NYSE:LEN

$127.17 -5.70 (-4.29%)
Closing price 03:59 PM Eastern
Extended Trading
$127.38 +0.20 (+0.16%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lennar Corporation, together with its subsidiaries, operates as a homebuilder primarily under the Lennar brand in the United States. It operates through Homebuilding East, Homebuilding Central, Homebuilding Texas, Homebuilding West, Financial Services, Multifamily, and Lennar Other segments. The company's homebuilding operations include the construction and sale of single-family attached and detached homes, as well as the purchase, development, and sale of residential land; and development, construction, and management of multifamily rental properties. It also offers residential mortgage financing, title, insurance, and closing services for home buyers and others, as well as originates and sells securitization commercial mortgage loans. In addition, the company is involved in the fund investment activity. It primarily serves first-time, move-up, active adult, and luxury homebuyers. Lennar Corporation was founded in 1954 and is based in Miami, Florida.

ODP stock logo

ODP NASDAQ:ODP

$20.82 -1.00 (-4.58%)
Closing price 04:00 PM Eastern
Extended Trading
$20.83 +0.01 (+0.05%)
As of 06:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The ODP Corporation provides business services and supplies, products, and digital workplace technology solutions for small, medium, and enterprise businesses in the United States, Puerto Rico, and the U.S. Virgin Islands. The company operates through four divisions: ODP Business Solutions, Office Depot, Veyer, and Varis. The ODP Business Solutions division offers adjacency products, including cleaning, janitorial, and breakroom supplies, office furniture, technology products; and copy and print services through sales force, catalogs, telesales, and through Internet websites. This segment also engages in office supply distribution business. The Office Depot division sells office supplies, technology products and solutions, business machines and related supplies, cleaning, breakroom and facilities products, personal protective equipment, and office furniture; and offers business services, including copying, printing, digital imaging, mailing, shipping, and technology support services through a fully integrated omni-channel platform of 980 Office Depot and OfficeMax retail stores, and through www.officedepot.com. The Veyer division engages in supply chain, distribution, procurement, and global sourcing operations. The Varis division operates tech-enabled B2B indirect procurement marketplace, where buyers and suppliers to transact through the platform's consumer-like buying experience, advanced spend management tools, network of suppliers, and technology capabilities. The company offers its products under various brands, including Office Depot, OfficeMax, and Grand&Toy, as well as others. The ODP Corporation was incorporated in 1986 and is headquartered in Boca Raton, Florida.